Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 21, 2026 10:25 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag Dilafor ingår bindande term sheet med Exeltis gällande licens avseende tafoxiparin

STOCKHOLM, 21 januari 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Dilafor har ingått ett bindande term sheet med det globala kvinnohälsoföretaget Exeltis...
January 21, 2026 10:25 ET | Source: Karolinska Development AB (publ)

Karolinska Development’s portfolio company Dilafor signs binding term sheet with Exeltis for a license agreement regarding tafoxiparin

STOCKHOLM, SWEDEN – January 21, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Dilafor has signed a binding term sheet with Exeltis, a global...